Exome sequencing-based screening for pathogenic variants in cancer susceptibility genes allows for more complete coverage of potential mutations (single nucleotide variations, insertions, deletions and structural variations). Genetron Health helps customers identify their “hidden” cancer risk and develop prevention and health management plans based on individual customer’s genetic makeup. The types of cancer involved include rectal, gastric, pancreatic, renal, thyroid, head and neck, breast, ovarian, endometrial, prostate, multiple endocrine tumors, retinoblastoma, melanoma, pheochromocytoma, chondrosarcoma, and multiple neurofibromas.